After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $165.70 and fluctuated between $169.35 as its day high and $164.53 as its day low. The current market capitalization of Insulet Corporation is $11.59B. A total of 0.76 million shares were traded on the day, compared to an average of 916.67K shares.
In the most recent transaction, Petrovic Shacey sold 11,609 shares of PODD for 162.92 per share on Feb 28 ’24. After the transaction, the Director now owns 2,567 company shares. In a previous transaction on Dec 15 ’23, BORIO LUCIANA sold 72 shares at 207.08 per share. PODD shares that Director owns now total 2,278.
Among the insiders who sold shares, Petrovic Shacey disposed of 20,000 shares on Nov 13 ’23 at a per-share price of $164.33. This resulted in the Director holding 2,567 shares of PODD after the transaction. In another insider transaction, Petrovic Shacey sold 15,000 shares at $165.02 per share on Nov 13 ’23. Company shares held by the Director now total 0.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, PODD has a high of $335.91 and a low of $125.82.
As of this writing, PODD has an earnings estimate of $0.39 per share for the current quarter. EPS was calculated based on a consensus of 16 estimates, with a high estimate of $0.61 per share and a lower estimate of $0.29. The company reported an EPS of $0.71 in the last quarter, which was 77.50% higher than expectations of $0.4.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PODD’s latest balance sheet shows that the firm has $790.00M in Cash & Short Term Investments as of fiscal 2021. There were $1.27B in debt and $228.80M in liabilities at the time. Its Book Value Per Share was $10.48, while its Total Shareholder’s Equity was $556.30M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PODD is Buy with a score of 4.61.
